Literature DB >> 15358120

Cyclin D3 interacts with human activating transcription factor 5 and potentiates its transcription activity.

Wenjin Liu1, Maoyun Sun, Jianhai Jiang, Xiaoyun Shen, Qing Sun, Weicheng Liu, Hailian Shen, Jianxin Gu.   

Abstract

The Cyclin D3 protein is a member of the D-type cyclins. Besides serving as cell cycle regulators, D-type cyclins have been reported to be able to interact with several transcription factors and modulate their transcriptional activations. Here we report that human activating transcription factor 5 (hATF5) is a new interacting partner of Cyclin D3. The interaction was confirmed by in vivo coimmunoprecipitation and in vitro binding analysis. Neither interaction between Cyclin D1 and hATF5 nor interaction between Cyclin D2 and hATF5 was observed. Confocal microscopy analysis showed that Cyclin D3 could colocalize with hATF5 in the nuclear region. Cyclin D3 could potentiate hATF5 transcriptional activity independently of its Cdk4 partner. But Cyclin D1 and Cyclin D2 had no effect on hATF5 transcriptional activity. These data provide a new clue to understand the new role of Cyclin D3 as a transcriptional regulator.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15358120     DOI: 10.1016/j.bbrc.2004.07.053

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  14 in total

1.  Evidence for CDK-dependent and CDK-independent functions of the murine gammaherpesvirus 68 v-cyclin.

Authors:  Jason W Upton; Samuel H Speck
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

2.  Protein expression pattern of CDK11(p58) during testicular development in the mouse.

Authors:  Ziyue Niu; Aiguo Shen; Hailian Shen; Jianhai Jiang; Hongliang Zong; Jianxin Gu
Journal:  Mol Cell Biochem       Date:  2005-02       Impact factor: 3.396

3.  Expression and targeting of transcription factor ATF5 in dog gliomas.

Authors:  D York; C D Sproul; N Chikere; P J Dickinson; J M Angelastro
Journal:  Vet Comp Oncol       Date:  2017-05-08       Impact factor: 2.613

4.  Overexpression of activating transcription factor 5 in human rectal cancer.

Authors:  Xiangheng Kong; Wenjian Meng; Zongguang Zhou; Yuan Li; Bin Zhou; Rong Wang; Lan Zhan
Journal:  Exp Ther Med       Date:  2011-06-27       Impact factor: 2.447

5.  Cyclin D3 promotes adipogenesis through activation of peroxisome proliferator-activated receptor gamma.

Authors:  David A Sarruf; Irena Iankova; Anna Abella; Said Assou; Stéphanie Miard; Lluis Fajas
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

6.  Gene network analysis during early infection of human coronary artery smooth muscle cells by Trypanosoma cruzi and Its gp83 ligand.

Authors:  Pius N Nde; Candice A Johnson; Siddharth Pratap; Tatiana C Cardenas; Yuliya Y Kleshchenko; Vyacheslav A Furtak; Kaneatra J Simmons; Maria F Lima; Fernando Villalta
Journal:  Chem Biodivers       Date:  2010-05       Impact factor: 2.408

7.  Cyclin D3 promotes pancreatic β-cell fitness and viability in a cell cycle-independent manner and is targeted in autoimmune diabetes.

Authors:  Noemí Alejandra Saavedra-Ávila; Upasana Sengupta; Begoña Sánchez; Ester Sala; Laura Haba; Thomas Stratmann; Joan Verdaguer; Dídac Mauricio; Belén Mezquita; Ana Belén Ropero; Ángel Nadal; Conchi Mora
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-04       Impact factor: 11.205

8.  Potential gene regulatory role for cyclin D3 in muscle cells.

Authors:  Fathima Athar; Veena K Parnaik
Journal:  J Biosci       Date:  2015-09       Impact factor: 1.826

Review 9.  Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases.

Authors:  Per Hydbring; Marcos Malumbres; Piotr Sicinski
Journal:  Nat Rev Mol Cell Biol       Date:  2016-04-01       Impact factor: 94.444

10.  Cyclin D2 is a GATA4 cofactor in cardiogenesis.

Authors:  Abir Yamak; Branko V Latinkic; Rola Dali; Rana Temsah; Mona Nemer
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-13       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.